Nimbus Therapeutics

Nimbus uses a collaborative, structure-based drug discovery approach, combining deep expertise and advanced technologies to identify and treat challenging disease targets in immunology, oncology, and metabolism. Cutting-edge computational chemistry and structural biology tools—like X-ray crystallography, cryo-EM, and Schrödinger’s physics-based modeling are used to design novel, potent, and selective small molecule therapies that target proteins central to disease but were previously difficult to treat.

Already a known leader in their specialty, we were tasked to rebrand the Nimbus look and feel to reflect a modern, cutting-edge firm that showcases their unique protein solutions central to patient outcomes and highlight the broad, dedicated team behind the technology and every day operations of the company.